Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 63629-8323

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 63629-8323). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 01)

FDA Label Image

Image-2 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 02)

Image-2 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 02)
This appears to be a chart showing the concentration of Tramadol in ng/mL over time for two different types of medications: Tramadol Hydrochloride Extended-Release Tablets (200 mg q.d) and Tramadol Hydrochloride Tablets (50 mg g6h). The chart includes units of measurement and a legend indicating which line represents which medication.*
FDA Label Image

Image-3 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 03)

Image-3 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 03)
This is a chart showing the concentration (in ng/mL) of M1 over time (in hours) for two different forms of Tramadol Hydrochloride: extended-release tablets (200 mg once daily) and regular tablets (50 mg every 6 hours).*
FDA Label Image

Image-4 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 04)

Image-4 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 04)
This appears to be a graph showing the percentage of patients who achieved various levels of pain relief with Tramadol Hydrochloride Extended-Release Tablets in a study analyzing WOMAC Pain Responder. The graph shows the percentage of patients who achieved different levels of response threshold for the medication based on different dosages of the extended-release tablets. A placebo group is also included for comparison. The graph includes a legend indicating which line represents each dosage level.*
FDA Label Image

Image-5 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 05)

Image-5 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 05)
The text describes the results of a study (Study 015) on Tramadol Hydrochloride Extended-Release Tablets for the relief of arthritis pain. The study examines the percentage of patients who achieved various levels of pain relief response, measured using a Visual Analog Scale (VAS). The data is presented in a chart showing the percent of patients achieving response thresholds at various levels of improvement from baseline, compared to a placebo group.*
FDA Label Image

Label (Lbl636298323)

Label (Lbl636298323)
This appears to be a label of a medication package. The medication is a prepackaged tablet, possibly containing oxycodone, and is being compared to Ultram ER 100mg tablet by Lupin Limited. The label includes details such as quantity, expiration date, and storage instructions. The NDC code of the medication is also provided. The label cautions to keep the medication out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.